Drug lookup
Drug reference

lugol solution

ionic inhibitor, antithyroid drug (iodine preparation) · antithyroid, radiation protection

ionic inhibitor, antithyroid drug (iodine preparation)antithyroid, radiation protection
CDSCO approved
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

Consists of 5% iodine and 10% potassium iodide, yielding about 8 mg of iodine per drop. Provides iodide that acutely reduces the secretion and synthesis of thyroid hormone.

Indications

preoperative period in preparation for thyroidectomyin conjunction with antithyroid drugs and propranolol in the treatment of thyrotoxic crisisprotection from radioactive iodine fallout

Dosing

Adult
16 to 36 mg (2–6 drops) three times a day.

Contraindications

  • pregnancy

Side effects

Common
iodism (unpleasant brassy taste, burning in the mouth and throat, soreness of the teeth and gums, increased salivation, coryza, sneezing, irritation of the eyes with swelling of the eyelids, mild iodism simulates a "head cold", enlarged and tender parotid and submaxillary glands, skin lesions, gastric irritation, diarrhea, fever, anorexia, depression)
Serious
  • angioedema
  • laryngeal edema (may lead to suffocation)
  • multiple cutaneous hemorrhages
  • serum sickness type of hypersensitivity (fever, arthralgia, lymph node enlargement, eosinophilia)
  • thrombotic thrombocytopenic purpura
  • fatal periarteritis nodosa
  • severe and sometimes fatal eruptions (ioderma)

Related guidelines

Other ionic inhibitor, antithyroid drug (iodine preparation) drugs

Ask House about lugol solution

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team